“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

Though lung cancer is still the deadliest cancer, causing 1 in 5 cancer deaths, most eligible for annual lung cancer ...

Secondary prevention for lung cancer involves screening methods that aim to detect the disease in its early stages, before ...

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors, raising ...

Radiation is one of the most effective ways to kill a tumor. But these therapies are indiscriminate, and they can damage ...

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors on Monday ...

The National Health Insurance (NHI) cannot provide the best care for people with lung cancer despite government goals to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...

AstraZeneca Plc’s drug Tagrisso won clearance in the European Union for an advanced form of non-small cell lung cancer, extending the revenue potential for the drugmaker’s top-selling cancer medicine.

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced ...